These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34206474)

  • 41. Interplay between ESKAPE Pathogens and Immunity in Skin Infections: An Overview of the Major Determinants of Virulence and Antibiotic Resistance.
    Vale de Macedo GHR; Costa GDE; Oliveira ER; Damasceno GV; Mendonça JSP; Silva LDS; Chagas VL; Bazán JMN; Aliança ASDS; Miranda RCM; Zagmignan A; Monteiro AS; Nascimento da Silva LC
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33540588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality.
    Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD
    Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.
    Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ
    mSystems; 2018; 3(3):. PubMed ID: 29719870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retrospective Analysis on Antimicrobial Resistance Trends and Prevalence of β-lactamases in
    Nasser M; Palwe S; Bhargava RN; Feuilloley MGJ; Kharat AS
    Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33096921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.
    Tiwari V; Meena K; Tiwari M
    Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycoconjugate vaccines against antimicrobial resistant pathogens.
    Sorieul C; Dolce M; Romano MR; Codée J; Adamo R
    Expert Rev Vaccines; 2023; 22(1):1055-1078. PubMed ID: 37902243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mortality Predictors in Acute Respiratory Distress Syndrome Renal Transplant Recipients With ESKAPE/rESKAPE Pneumonia.
    Chu L; Ye QF; Wan QQ; Zhou JD
    Transplant Proc; 2015 Oct; 47(8):2450-5. PubMed ID: 26518949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent advances to combat ESKAPE pathogens with special reference to essential oils.
    Panda SK; Buroni S; Swain SS; Bonacorsi A; da Fonseca Amorim EA; Kulshrestha M; da Silva LCN; Tiwari V
    Front Microbiol; 2022; 13():1029098. PubMed ID: 36560948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in the development of antimicrobial peptides against ESKAPE pathogens.
    Roque-Borda CA; Primo LMDG; Franzyk H; Hansen PR; Pavan FR
    Heliyon; 2024 Jun; 10(11):e31958. PubMed ID: 38868046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensitizing pathogens to antibiotics using the CRISPR-Cas system.
    Goren M; Yosef I; Qimron U
    Drug Resist Updat; 2017 Jan; 30():1-6. PubMed ID: 28363331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of Enterococcus , Staphylococcus aureus , Klebsiella , Acinetobacter , Pseudomonas , and Enterobacter Species Transmission in the Pediatric Anesthesia Work Area Environment With and Without Practitioner Use of a Personalized Body-Worn Alcohol Dispenser.
    Fernandez PG; Dexter F; Brown J; Whitney G; Koff MD; Cao S; Loftus RW
    Anesth Analg; 2024 Jan; 138(1):152-160. PubMed ID: 36623234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photoinactivation of ESKAPE pathogens: overview of novel therapeutic strategy.
    Nakonieczna J; Wozniak A; Pieranski M; Rapacka-Zdonczyk A; Ogonowska P; Grinholc M
    Future Med Chem; 2019 Mar; 11(5):443-461. PubMed ID: 30901231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxin-Antitoxin Systems in Clinical Pathogens.
    Fernández-García L; Blasco L; Lopez M; Bou G; García-Contreras R; Wood T; Tomas M
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27447671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century.
    Čivljak R; Giannella M; Di Bella S; Petrosillo N
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):249-64. PubMed ID: 24392752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fine-Tuning of Alkaline Residues on the Hydrophilic Face Provides a Non-toxic Cationic α-Helical Antimicrobial Peptide Against Antibiotic-Resistant ESKAPE Pathogens.
    Luo X; Ye X; Ding L; Zhu W; Yi P; Zhao Z; Gao H; Shu Z; Li S; Sang M; Wang J; Zhong W; Chen Z
    Front Microbiol; 2021; 12():684591. PubMed ID: 34335511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathogenic Characteristics and Risk Factors for ESKAPE Pathogens Infection in Burn Patients.
    Li Z; Xie J; Yang J; Liu S; Ding Z; Hao J; Ding Y; Zeng Z; Liu J
    Infect Drug Resist; 2021; 14():4727-4738. PubMed ID: 34795489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Are Antimicrobial Peptide Dendrimers an Escape from ESKAPE?
    Kawano Y; Jordan O; Hanawa T; Borchard G; Patrulea V
    Adv Wound Care (New Rochelle); 2020 May; 9(7):378-95. PubMed ID: 32320368
    [No Abstract]   [Full Text] [Related]  

  • 60. Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE Pathogens.
    Behroozian S; Svensson SL; Davies J
    mBio; 2016 Jan; 7(1):e01842-15. PubMed ID: 26814180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.